Hepatitis C virus core protein discriminates between the two IgG2 allotypes.

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Immunoglobulin GM allotypes, genetic markers of IgG, are linked to hepatitis C virus (HCV) infection outcomes.
• HCV employs immune evasion strategies, potentially involving its core protein scavenging anti-HCV IgG antibodies.
• The precise mechanisms by which GM allotypes influence HCV infection are not fully elucidated.

Purpose of the Study:

• To investigate whether GM allotypes modulate HCV's immune evasion strategy through differential binding to the viral core protein.
• To test the hypothesis that variations in GM allotypes affect the interaction between IgG antibodies and the HCV core protein.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure the binding of IgG2 antibodies with different GM allotypes (GM23+ and GM23-) to the HCV core protein.
• Statistical analysis (p-value) was employed to determine the significance of observed binding differences.

Main Results:

• Higher absorbance values were observed for the binding of GM23+IgG2 compared to GM23-IgG2 to the HCV core protein (p = 0.027).
• This differential binding suggests a mechanism by which GM allotypes influence the interaction with the viral core protein.

Conclusions:

• The differential binding of GM allotypes to the HCV core protein provides a partial explanation for the association between GM allotypes and HCV infection outcomes.
• These findings contribute to understanding the mechanisms underlying GM allotype influence on host defense against HCV and the maintenance of genetic linkage disequilibrium.